Achieve Life Sciences Stock (NASDAQ: ACHV) stock price, news, charts, stock research, profile.
Open | $4.99 |
Close | $4.93 |
Volume / Avg. | 62.32K / 243.83K |
Day Range | 4.80 - 5.00 |
52 Wk Range | 3.03 - 5.98 |
Market Cap | $169.13M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 9.17% |
Days to Cover | 14.44 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Achieve Life Sciences (NASDAQ:ACHV) through any online brokerage.
Other companies in Achieve Life Sciences’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Renovaro (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE) and Galectin Therapeutics (NASDAQ:GALT).
There is no analysis for Achieve Life Sciences.
Achieve Life Sciences has a consensus price target of $15.00.
The stock price for Achieve Life Sciences (NASDAQ: ACHV) is $4.925 last updated July 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Achieve Life Sciences.
Achieve Life Sciences’s Q2 earnings are confirmed for Tuesday, August 13, 2024.
There is no upcoming split for Achieve Life Sciences.
Achieve Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.